VIKING GLOBAL INVESTORS LP 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:23 am Unchanged | 2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 20.700% | 0 (Unchanged) | Filing |
| 2022-02-14 5:02 pm Unchanged | 2021-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.300% | 0 (Unchanged) | Filing |
| 2021-02-12 7:38 pm Sale | 2020-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.900% | -8,412,899 (-21.90%) | Filing |
| 2021-02-12 1:09 pm Purchase | 2020-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | VIKING GLOBAL INVESTORS LP | 16,382,663 5.800% | 16,382,663 (New Position) | Filing |